Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Schering-Plough Settles U.S. Pricing Investigation | Contract Pharma

What are you searching for?

Sign in
Breaking News

Schering-Plough Settles U.S. Pricing Investigation

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Schering-Plough Corp. has reached an agreement with the U.S. Attorney’s Office for the District of Massachusetts and the U.S. Department of Justice to settle the investigation involving the company’s sales, marketing and clinical trial practices and programs.

The agreement resolves the investigation, which began prior to the arrival of the current management team. The agreement provides for a settlement of $435 million, subject to court approval. Under the agreement, Schering Sales Corp., a subsidiary of Schering-Plough, will plead guilty to one count of conspiracy to make false statements to the government and pay a criminal fine of $180 million, and Schering-Plough will pay $255 million to resolve civil aspects of the investigation.

In connection with the settlement, Schering-Plough will also sign an addendum to an existing corporate integrity agreement with the Office of Inspector General (OIG) of the U.S. Department of Health and Human Services (HHS). The addendum will not affect the company’s ongoing business with any customers, including the federal government.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters